Statistics

Total Visits

Views
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 187

Total Visits per Month

August 2015 September 2015 October 2015 November 2015 December 2015 January 2016 February 2016
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 4 0 0 0 2 0 0

File Downloads

Views
ijo_34_4_1155_PDF published.pdf 63

Top Country Views

Views
United States 42
Germany 22
Sweden 20
Canada 18
China 17
France 11
United Kingdom 9
South Korea 5
Russia 5
India 2

Top City Views

Views
Miami Beach 17
Nynäs 17
Toronto 13
Beijing 7
Kansas City 5
Zhengzhou 5
Seoul 3
Ottawa 2
Bangalore 1
Cambridge 1